When to Use FBS vs 75g OGTT in Pregnant Women
For pregnant women with a history of GDM, perform early screening with FBS (or any glucose test) at the first prenatal visit (12-14 weeks), and if negative, mandatory 75g OGTT screening at 24-28 weeks. 1, 2
Early Pregnancy Screening (First Prenatal Visit)
Who Needs Early Screening
Women with the following risk factors should be tested at their first prenatal visit (typically 12-14 weeks):
- History of previous GDM (4.14 times higher risk) 2
- BMI ≥30 kg/m² 2
- Family history of diabetes in first-degree relatives 2
- High-risk ethnicity (Hispanic, Native American, South or East Asian, African American, Pacific Islander) 2
- History of delivering macrosomic baby (>4.05 kg) 2
- History of polycystic ovary syndrome 2
What Test to Use Early
At the first prenatal visit, use FBS or random plasma glucose to detect overt (pre-existing) diabetes, not GDM: 1, 3
- FBS ≥126 mg/dL = overt diabetes (not GDM) 1
- Random glucose ≥200 mg/dL with symptoms = overt diabetes 1
- FBS 92-125 mg/dL = diagnose as GDM 1
- FBS <92 mg/dL = proceed to 75g OGTT at 24-28 weeks 1
Critical point: Early screening is designed to catch pre-existing undiagnosed type 2 diabetes, not true GDM which develops later in pregnancy. 2 The 75g OGTT is not routinely recommended before 24 weeks even in high-risk women. 1
Standard Screening at 24-28 Weeks (Mandatory for All)
Universal Screening Window
All pregnant women not previously diagnosed with overt diabetes or GDM must undergo screening at 24-28 weeks, including those who tested negative early. 1, 2, 4
Two Screening Approaches
One-Step Approach (75g OGTT):
- Perform fasting 75g OGTT with measurements at fasting, 1-hour, and 2-hour 1, 4
- Diagnosis requires only ONE abnormal value: 1, 4, 5
- Fasting ≥92 mg/dL
- 1-hour ≥180 mg/dL
- 2-hour ≥153 mg/dL
Two-Step Approach (50g GCT → 100g OGTT):
- Initial 50g glucose challenge test (non-fasting) 1, 2
- If 1-hour glucose ≥140 mg/dL, proceed to fasting 100g OGTT 1
- Diagnosis requires at least TWO abnormal values: 1, 4
- Fasting ≥95 mg/dL
- 1-hour ≥180 mg/dL
- 2-hour ≥155 mg/dL
- 3-hour ≥140 mg/dL
The American College of Obstetricians and Gynecologists currently supports the two-step approach, while the American Diabetes Association endorses the one-step approach. 4
Postpartum Follow-Up
Immediate Postpartum Testing
All women diagnosed with GDM must undergo 75g OGTT at 4-12 weeks postpartum using non-pregnancy diagnostic criteria. 1, 4, 5
Why 75g OGTT and not FBS or A1C postpartum?
- A1C may be falsely lowered by increased red blood cell turnover during pregnancy, blood loss at delivery, or the preceding glucose profile 1
- The 75g OGTT is more sensitive at detecting glucose intolerance including both prediabetes and diabetes 1
Long-Term Surveillance
Women with history of GDM require lifelong screening for diabetes at least every 1-3 years using any glycemic test (A1C, FBS, or 75g OGTT). 1, 2, 4, 5
Common Pitfalls to Avoid
Not repeating screening at 24-28 weeks in high-risk women who initially test negative leads to delayed diagnosis and treatment. 2 Even with normal early screening, GDM typically develops in the second/third trimester due to increasing insulin resistance.
Using A1C for postpartum diagnosis is unreliable due to pregnancy-related changes in red blood cell turnover. 1 Always use 75g OGTT at 4-12 weeks postpartum.
Performing 75g OGTT before 24 weeks routinely is not recommended even in high-risk women, as there is insufficient evidence of benefit. 1 Use FBS or random glucose for early screening instead.
Failing to screen high-risk women early may miss pre-existing undiagnosed type 2 diabetes, particularly in women with BMI ≥30 kg/m². 2